These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients. Wong JY; Chu DZ; Yamauchi D; Odom-Maryon TL; Williams LE; Liu A; Esteban JM; Wu AM; Primus FJ; Beatty JD; Shively JE; Raubitschek AA J Nucl Med; 1998 Dec; 39(12):2097-104. PubMed ID: 9867150 [TBL] [Abstract][Full Text] [Related]
9. Iodine-123-vascular endothelial growth factor-165 (123I-VEGF165). Biodistribution, safety and radiation dosimetry in patients with pancreatic carcinoma. Li S; Peck-Radosavljevic M; Kienast O; Preitfellner J; Havlik E; Schima W; Traub-Weidinger T; Graf S; Beheshti M; Schmid M; Angelberger P; Dudczak R Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):198-206. PubMed ID: 15499293 [TBL] [Abstract][Full Text] [Related]
10. Radiation dosimetry of a 99mTc-labeled IgM murine antibody to CD15 antigens on human granulocytes. Mozley PD; Stubbs JB; Dresel SH; Barraclough ED; Smith T; Patel M; Finkelman C; Sparks RB; Thakur ML; Mathur A; Alavi A J Nucl Med; 1999 Apr; 40(4):625-30. PubMed ID: 10210221 [TBL] [Abstract][Full Text] [Related]
11. Radiation dosimetry for indium-111-pentetreotide. Stabin MG; Kooij PP; Bakker WH; Inoue T; Endo K; Coveney J; de Jong R; Minegishi A J Nucl Med; 1997 Dec; 38(12):1919-22. PubMed ID: 9430470 [TBL] [Abstract][Full Text] [Related]
12. Dosimetry of 188Re-hydroxyethylidene diphosphonate in human prostate cancer skeletal metastases. Liepe K; Hliscs R; Kropp J; Runge R; Knapp FF; Franke WG J Nucl Med; 2003 Jun; 44(6):953-60. PubMed ID: 12791825 [TBL] [Abstract][Full Text] [Related]
13. Biodistribution and dosimetry of 195mPt-cisplatin in normal volunteers. Imaging agent for single photon emission computed tomography. Sathekge M; Wagener J; Smith SV; Soni N; Marjanovic-Painter B; Zinn C; Van de Wiele C; D'Asseler Y; Perkins G; Zeevaart JR Nuklearmedizin; 2013 Dec; 52(6):222-7. PubMed ID: 24108524 [TBL] [Abstract][Full Text] [Related]
14. Dosimetric evaluation of immunoscintigraphy using indium-111-labeled monoclonal antibody fragments in patients with ovarian cancer. Buijs WC; Massuger LF; Claessens RA; Kenemans P; Corstens FH J Nucl Med; 1992 Jun; 33(6):1113-20. PubMed ID: 1597725 [TBL] [Abstract][Full Text] [Related]
15. Dynamic distribution and dosimetric evaluation of human non-specific immunoglobulin G labelled with 111In or 99Tcm. Buijs WC; Oyen WJ; Dams ET; Boerman OC; Siegel JA; Claessens RA; van der Meer JW; Corstens FH Nucl Med Commun; 1998 Aug; 19(8):743-51. PubMed ID: 9751928 [TBL] [Abstract][Full Text] [Related]
16. A compartmental model for biokinetics and dosimetry of 18F-choline in prostate cancer patients. Giussani A; Janzen T; Uusijärvi-Lizana H; Tavola F; Zankl M; Sydoff M; Bjartell A; Leide-Svegborn S; Söderberg M; Mattsson S; Hoeschen C; Cantone MC J Nucl Med; 2012 Jun; 53(6):985-93. PubMed ID: 22570328 [TBL] [Abstract][Full Text] [Related]
17. Safety, biodistribution, and dosimetry of 123I-IMPY: a novel amyloid plaque-imaging agent for the diagnosis of Alzheimer's disease. Newberg AB; Wintering NA; Plössl K; Hochold J; Stabin MG; Watson M; Skovronsky D; Clark CM; Kung MP; Kung HF J Nucl Med; 2006 May; 47(5):748-54. PubMed ID: 16644743 [TBL] [Abstract][Full Text] [Related]